VeriMomIst salicyloyl oligopeptide-143 in der Schwangerschaft sicher?
No harmonised CLP classification, no CIR or SCCS safety assessment specifically for salicyloyl oligopeptide-143, and no peer‑reviewed reproductive/toxicity studies identified (sources searched: ECHA Annex VI, CIR, SCCS, PubMed, ECHA dossiers, CosIng, PubChem, EWG). The only plausible theoretical concern is that the salicyloyl group could release salicylic acid, but there is no direct evidence that this ingredient causes reproductive toxicity. Therefore hazard = 0 (no evidence), mechanism = 1 (theoretical only: potential release of salicylate), exposure = 1 (topical cosmetic use — low but potentially measurable absorption).
Related ingredients
Frequently asked questions
- Ist salicyloyl oligopeptide-143 in der Schwangerschaft sicher?
- No harmonised CLP classification, no CIR or SCCS safety assessment specifically for salicyloyl oligopeptide-143, and no peer‑reviewed reproductive/toxicity studies identified (sources searched: ECHA Annex VI, CIR, SCCS, PubMed, ECHA dossiers, CosIng, PubChem, EWG). The only plausible theoretical concern is that the salicyloyl group could release salicylic acid, but there is no direct evidence that this ingredient causes reproductive toxicity. Therefore hazard = 0 (no evidence), mechanism = 1 (theoretical only: potential release of salicylate), exposure = 1 (topical cosmetic use — low but potentially measurable absorption).
- Ist salicyloyl oligopeptide-143 während des Stillens sicher?
- Same rationale as pregnancy. No specific data showing transfer into milk or effects on lactation; theoretical concern only via possible salicylate release. For normal cosmetic topical use exposure is expected to be low.
- Ist salicyloyl oligopeptide-143 sicher für Babyhaut?
- No infant-specific toxicology or clinical data located. Hazard remains 0 (no evidence). Mechanistic concern is theoretical only (possible salicyloyl → salicylic acid). Exposure score increased by +1 for infants due to immature barrier and higher surface‑area‑to‑weight, so e = 2 (moderate relative exposure).
- Wie bewertet VeriMom salicyloyl oligopeptide-143?
- VeriMom bewertet salicyloyl oligopeptide-143 mit 87/100 (geringes Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu salicyloyl oligopeptide-143?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu salicyloyl oligopeptide-143 basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.